May 25, 2021, 13:16 PM by

MedPharm announces complete refurbishment and modernization of its 15,000 sq ft campus in Surrey, UK.

May 25, 2021, 13:16 PM by

The agreement will further enable global supply of mRNA-1273, Moderna’s COVID-19 vaccine with Samsung Biologics’ fill and finish manufacturing service

May 25, 2021, 13:16 PM by

May 25, 2021, 13:16 PM by

May 25, 2021, 13:16 PM by

May 25, 2021, 13:16 PM by

May 25, 2021, 13:16 PM by

The liquid stable and ready-to-use MATRIX PLUS™ Cholesterol Reference Kit, containing known concentrations of both Cholesterol and Uric Acid and expressly designed to support overall system QC and CLIA compliance, is now available from VERICHEM LABORATORIES.

May 25, 2021, 13:16 PM by

US Orthopedic Alliance (USOA) selected 2bPrecise to provide its precision medicine platform to USOA’s network of more than 100 orthopedic surgeons.

May 25, 2021, 13:16 PM by

May 25, 2021, 13:16 PM by

May 20, 2021, 01:00 AM by User Not Found

Bio-IT World | Vizgen has released its first freely-available dataset as part of its newly-launched Vizgen Data Release Program. The Vizgen MERFISH Mouse Brain Receptor Map is an open-source spatial genomics dataset containing the exact position of transcripts from 483 genes across three full coronal slices with three biological replicates for each slice.

May 19, 2021, 01:00 AM by User Not Found

Bio-IT World | The Institute for Genomic Health at Mount Sinai Health System is launching pilot programs in the clinic based on discoveries from genomic research to evaluate their real-world utility. Where genomics data proves useful, the necessary infrastructure then gets built in terms of educating medical professionals and creating navigational paths for patients to bring that information to bear in clinical decision-making.

May 18, 2021, 01:00 AM by User Not Found

Bio-IT World | Glenn Lockwood serves as a storage architect at the National Energy Research Scientific Computing Center based at Lawrence Berkeley National Laboratory. In this role, he’s had a front-row seat to the changing demands of science on storage.

May 14, 2021, 11:41 AM by User Not Found

Bio-IT World | The laboratory of the future does not look at all like what we think of today but will instead be a network of physical and virtual spaces, spanning the entire lifecycle of therapeutic products. Robot-guided molecular and cellular biology labs test predictions of new chemicals generated in the cloud. Biomarkers derived from organs on a chip and federated global clinical trials yield patient-precise clinician reports. Sensors monitor compliance and collect troves of data over time. In fact, all of these technologies are here today, but the laboratory of the future will learn to connect them into constellations of discovery.

May 13, 2021, 01:00 AM by User Not Found

Bio-IT World | Large protein nanomachines produced by bacteria to selectively annihilate other members of their microbial community could one day be weaponized for wiping out undesirable inhabitants of the human microbiome known to cause ill health and disease.

May 12, 2021, 01:00 AM by User Not Found

Bio-IT World | In a research letter published last week in JAMA, St Jude Children’s Research Hospital researchers reported early findings tracking asymptomatic COVID-19 among vaccinated healthcare workers. The findings will inform both individual vaccination plans as well as institutional screening and testing programs.

May 10, 2021, 01:00 AM by User Not Found

Bio-IT World | The University of California, San Francisco’s (UCSF) Quantitative Biosciences Institute (QBI) spearheaded a six-nation collaborative around COVID-19 that now has 26 potential treatments in clinical trials.

May 6, 2021, 01:00 AM by User Not Found

Bio-IT WorldWhile the vast majority of R&D procurement may never be as easy as point-and-click, we can look to consumer marketplaces for ideas on how to improve the overall life science buying experience.

May 4, 2021, 01:00 AM by User Not Found

Bio-IT World | Big pharma has invested billions of dollars in developing antibodies targeting death receptor 5 (DR5) over the years in hopes of improving the survival of patients with cancer. While promising when tested in mice in the lab, they invariably failed to show efficacy during phase 2 clinical studies. But researchers at the University of Virginia now have a new theory that could revive them.

May 3, 2021, 01:00 AM by User Not Found

Bio-IT World | NIH grant tackles COVID-19 disparities, St. Jude launches historic expansion, Illumina all in on African Pathogen Genomics Initiative, and new platforms and services to ease drug and vaccine development. Plus: new storage from VAST Data, and new solutions for tracking research papers and patents.